4
Changes in Ownership
Pelthos Therapeutics Inc. Filed Acc 0001919246-26-000093
Director sold 283 shares at an average $27.29 ($7,724)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Friedberg Ezra M · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-15 | Sale : show line 1 in the form 10b5-1 | −224 | $27.12 | $6,076 | 81,659 | D |
| 2026-06-15 | Sale : show line 2 in the form 10b5-1 | −59 | $27.94 | $1,648 | 81,600 | D |
| Open-market sales · 283 sh · avg $27.29 · $7,724 | ||||||
Loading xslF345X06/wk-form4_1781731506.xml…